Plant Health Care PLC
LSE:PHC
Intrinsic Value
Plant Health Care Plc engages in the provision biological products. [ Read More ]
The intrinsic value of one
PHC
stock under the Base Case scenario is
36.02
GBX.
Compared to the current market price of 3.6 GBX,
Plant Health Care PLC
is
Undervalued by 90%.
Plant Health Care PLC's market capitalization is 12.3m GBX.
PHC stock price is 3.6 GBX.
PHC stock price (3.6 GBX) is 90% less than its Intrinsic Value (36.02 GBX).
PHC has downside potential of 89% compared to the average analyst price target.
Open Wall St Estimates
PHC's Revenue has grown by 13% over the past 12 months.
PHC's Revenue has been growing by 20% per year for the last 3 years.
PHC's ROE (Return on Equity) has significantly decreased in the last 3 years from -31% to -49%, and is approaching profitability.
PHC's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -45% to -88%, and is approaching profitability.
PHC's Revenue is forecast to grow at a rate of 41% per year over the next 3 years.
PHC has negative Operating Income for the last twelve months.
PHC has negative Net Income for the last twelve months.
PHC's ROE (Return on Equity) for the past 12 months is negative and is equal to -49%.
PHC's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -88%.
PHC has positive Gross Profit for the last twelve months.
PHC has negative Free Cash Flow for the last twelve months.
PHC's short-term assets (11m USD) exceed its short-term liabilties (3m USD).
PHC's D/E (Debt to Equity) is very low and is equal to 0.03.
PHC has negative three-year average ROE (Return on Equity): -49%. The company is not efficient at transforming stockholders' equity into net income.
PHC has negative three-year average ROIC (Return on Invested Capital): -89%. The company is not efficient at using invested capital to generate operating income.
PHC's long-term assets (14m USD) exceed its long-term liabilties (3m USD).
PHC has negative Net Debt. This means that the company has more cash and short-term investments (6m USD) than debt (296k USD).
PHC's Altman Z-Score is very low and is equal to -4.3.
PHC doesn't generate enough operating income (-6m USD) to safely cover interest payments on its debt (89k USD).
Valuation Backtest
Plant Health Care PLC
Run backtest to discover the historical profit from buying and selling
PHC
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Plant Health Care PLC
Balance Sheet Decomposition
Plant Health Care PLC
| Current Assets | 11.3m |
| Cash & Short-Term Investments | 5.7m |
| Receivables | 2.5m |
| Other Current Assets | 3.1m |
| Non-Current Assets | 3.1m |
| PP&E | 955k |
| Intangibles | 2m |
| Other Non-Current Assets | 159k |
| Current Liabilities | 3m |
| Accounts Payable | 2.5m |
| Other Current Liabilities | 456k |
| Non-Current Liabilities | 296k |
| Long-Term Debt | 296k |
Earnings Waterfall
Plant Health Care PLC
|
Revenue
|
11.8m
USD
|
|
Cost of Revenue
|
-4.7m
USD
|
|
Gross Profit
|
7.1m
USD
|
|
Operating Expenses
|
-12.7m
USD
|
|
Operating Income
|
-5.6m
USD
|
|
Other Expenses
|
-139k
USD
|
|
Net Income
|
-5.7m
USD
|
Free Cash Flow Analysis
Plant Health Care PLC
What is Free Cash Flow?
PHC Profitability Score
Profitability Due Diligence
Plant Health Care PLC's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Plant Health Care PLC's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
PHC Solvency Score
Solvency Due Diligence
Plant Health Care PLC's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
Plant Health Care PLC's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PHC Price Targets Summary
Plant Health Care PLC
According to Wall Street analysts, the average 1-year price target for
PHC
is 0.38 GBX
.
Shareholder Return
PHC Price
Plant Health Care PLC
| Average Annual Return | 11.77% |
| Standard Deviation of Annual Returns | 33.78% |
| Max Drawdown | -83% |
| Market Capitalization | 12.3m GBX |
| Shares Outstanding | 341 532 992 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Plant Health Care PLC
Country
Industry
Market Cap
Dividend Yield
Description
Plant Health Care Plc engages in the provision biological products. The company is headquartered in Raleigh, North Carolina and currently employs 45 full-time employees. The company went IPO on 2004-07-06. The firm's segments include Americas, Mexico, and Rest of World. The company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. Its biological products help growers to protect their crops from stress and diseases. Its lead product, Harpin ab, is a recombinant protein developed from the naturally occurring Harpin proteins, which act as a biostimulant, promoting the yield and quality of crops. The company is also focused on the research and development of its Plant Response Elicitor technology (PREtec) platform. The company is developing six lead products from three platforms, including Innatus 3G platform, which targets growth and disease resistance; T-Rex 3G platform, which targets nematode defense, while the Y-Max 3G platform delivers increased yield and growth.
Contact
IPO
Employees
Officers
The intrinsic value of one
PHC
stock under the Base Case scenario is
36.02
GBX.
Compared to the current market price of 3.6 GBX,
Plant Health Care PLC
is
Undervalued by 90%.
You don't have any saved screeners yet
